Overview of CLL12 trial of ibrutinib aiming to delay chemoimmunotherapy
Lymphoma highlights from EHA 2016
How to avoid tumor lysis syndrome when treating CLL patients with venetoclax
Transplantation versus novel therapies in high-risk chronic lymphoblastic leukemia (CLL)?
Nivolumab in combination with azacitidine in patients with relapsed acute myeloid leukemia (AML)
Naval G. Daver